Eunwoo Kim

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Squamous Cell Carcinoma

Anti Inflammatory Drugs

Top Venues

Clinical and translational science

Translational and clinical pharmacology

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Heejae Won, Eunwoo Kim, Jihye Chae, Hyejung Lee, Joo-Youn Cho, In-Jin Jang, Jae-Young Chung, Min Gul Kim, Seung Hwan Lee
Pharmacokinetic interactions between fexuprazan, a potassium-competitive acid blocker, and nonsteroidal anti-inflammatory drugs in healthy males. Clinical and translational science 17 (5) (2024)
Heejae Won, Eunwoo Kim, Jihye Chae, Hyejung Lee, Joo-Youn Cho, In-Jin Jang, Jae-Young Chung, Min Gul Kim, Seung Hwan Lee
Pharmacokinetic interactions between fexuprazan, a potassium-competitive acid blocker, and nonsteroidal anti-inflammatory drugs in healthy males. Clinical and translational science 17 (5) (2024)
Heejae Won, Eunwoo Kim, Jihye Chae, Hyejung Lee, Joo-Youn Cho, In-Jin Jang, Jae-Young Chung, Min Gul Kim, Seung Hwan Lee
Pharmacokinetic interactions between fexuprazan, a potassium-competitive acid blocker, and nonsteroidal anti-inflammatory drugs in healthy males. Clinical and translational science 17 (5) (2024)
Sangmi Lee, Eunwoo Kim, Seol Ju Moon, Jina Jung, Seung Hwan Lee, Kyung-Sang Yu
Comparative pharmacokinetics between tenofovir disoproxil phosphate and tenofovir disoproxil fumarate in healthy subjects. Translational and clinical pharmacology 29 (1) (2021)
Xuanyou Jin, Eunwoo Kim, Ki Young Huh, Inyoung Hwang, Joo-Youn Cho, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects. Translational and clinical pharmacology 28 (1) (2020)
Eunwoo Kim, Kyoung Ryun Park, In-Jin Jang, Kyung-Sang Yu, SeungHwan Lee
A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects. Drug design, development and therapy 13 (2019)